SCHEDULE 13G: BlackRock Discloses 68.7% Beneficial Ownership in iShares Trust Common Stock

BlackRock, Inc. has filed a Schedule 13G disclosing its beneficial ownership of 103,000 shares, representing 68.7% of the Common Stock of iShares Trust as of December 31, 2024.

Summary

• BlackRock, Inc. reported beneficial ownership of 103,000 shares of Common Stock in iShares Trust.
• This ownership represents 68.7% of the total class of securities.
• BlackRock, Inc. holds sole voting power and sole dispositive power over all 103,000 shares.
• The filing is a Schedule 13G, indicating passive investment intent, and is an amendment reflected as an initial filing due to technical issues.
• BlackRock Financial Management, Inc. MTM Consol, a subsidiary of BlackRock, Inc., holds more than five percent of the total outstanding common stock of iShares Neuroscience and Healthcare ETF.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. It does not contain positive or negative operational or financial news for the issuer, nor does it indicate a change in investment strategy that would significantly alter sentiment.

Positives

• The disclosure confirms a significant and stable ownership stake by BlackRock, Inc., a major global asset manager, in iShares Trust, which can be viewed positively for the stability and institutional backing of the issuer.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct." Spencer Fleming, Managing Director, BlackRock, Inc.

Industry Context

BlackRock, Inc. is one of the world's largest asset managers, and its iShares brand is a leading provider of exchange-traded funds (ETFs). This filing reflects a routine disclosure of a significant passive ownership stake by a major institutional investor in an investment trust, common within the asset management industry where large firms hold substantial positions across various funds and securities.

Related Party Transactions

• BlackRock Financial Management, Inc. MTM Consol, a subsidiary of BlackRock, Inc., is known to have an interest of more than five percent of the total outstanding common stock in iShares Neuroscience and Healthcare ETF.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant institutional ownership stake, which can offer a degree of stability and confidence due to BlackRock's reputation and passive investment intent.

Key Dates

Keywords

BlackRock, iShares Trust, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Asset Management, ETF